Capsaicinoids supplementation Nutritional, Metabolic, Endocrine Capsaicinoids supplementation
Conditions
Interventions
Following provision of informed consent, all participants are given 100 mg Capsimax (which contains 2 mg capsaicinoids) to take with their breakfast meal for 7 days.
On the first day of the study per
Sponsors
OmniActive Health Technologies Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged between 19-51 years 2. BMI of less than 40kg/m2 3. Provision of written informed consent
Exclusion criteria
Exclusion criteria: 1. Chronic disease/condition 2. Pregnancy or lactation 3. No dietary supplement consumption
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Appetite is measured using VAS questionnaires and subjective questionnaires at baseline and 7 days 2. Exercise habits are measured using surveys designed for the purpose of this study at baseline and 7 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Resting heart rate is measured manually by researchers at baseline and 7 days 2. Diastolic and systolic blood pressure is measured using a sphygmomanometer at baseline and 7 days | — |
Countries
United States of America
Outcome results
None listed